Description

// WHAT_IS_SEMAX

Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment — the brain-active segment of adrenocorticotropic hormone with no cortisol activity. Developed in Russia in the 1980s, researchers added a stabilizing Pro-Gly-Pro tail to create a nootropic compound designed for rapid blood-brain barrier penetration and central nervous system activity.

// MECHANISM_CASCADE

Research indicates Semax upregulates BDNF (Brain-Derived Neurotrophic Factor) — the protein behind neuron growth, memory formation, and neuroplasticity. Research indicates Semax triggers a BDNF cascade that supports learning and memory pathways.

// RESEARCH_DOMAINS

• Focus + Memory: Effects on attention, working memory, and cognitive performance in animal studies
• Neuroprotection: Animal research reports protection against ischemic and oxidative neural damage
• Dopamine + 5-HT Modulation: Reported modulation of dopamine and serotonin pathways tied to mood and motivation
• BDNF Upregulation: Supports neuroplasticity — the brain’s ability to rewire and adapt

// PROTOCOL_NOTES

Researchers reconstitute with bacteriostatic water prior to use. Subcutaneous injection is used in systemic research protocols. Typical research protocols use 200–600mcg per day, often cycled 10–20 days on / 10 days off. Frequently stacked with Selank as the classic “focus + calm” pairing.

// ORIGIN_STATUS

Russian clinical use is decades deep — Semax appears on Russia’s Vital and Essential Drugs List. However, large modern human trials remain limited outside Russia. Not FDA approved.

// DISCLAIMER

Research use only. Not for human consumption. Not medical advice. Educational content only.